Developing a universal vaccine for influenza
Centers for Research on Structural Biology of Infectious Diseases: Universal Influenza
['FUNDING_OTHER'] · SEATTLE CHILDREN'S HOSPITAL · NIH-11160407
This study is looking at the shapes of certain proteins linked to the flu to help create a better vaccine that could protect against many different strains of the virus, which could be really helpful for patients during flu season.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SEATTLE CHILDREN'S HOSPITAL (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11160407 on ClinicalTrials.gov |
What this research studies
This research focuses on using advanced structural biology techniques to understand the three-dimensional structures of proteins related to influenza. By characterizing these proteins, the goal is to facilitate the creation of a universal influenza vaccine that could provide broader protection against various strains of the virus. Patients may benefit from this research as it aims to improve vaccine efficacy and reduce the impact of influenza outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for influenza, such as young children, the elderly, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received a recent influenza vaccine may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and universal influenza vaccine, potentially reducing the incidence of influenza and its complications.
How similar studies have performed: Previous research in structural biology has shown promise in developing vaccines for other infectious diseases, indicating potential success for this novel approach in influenza vaccine development.
Where this research is happening
SEATTLE, UNITED STATES
- SEATTLE CHILDREN'S HOSPITAL — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MYLER, PETER — SEATTLE CHILDREN'S HOSPITAL
- Study coordinator: MYLER, PETER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder